Balyasny Asset Management
TTOO

Balyasny Asset Management’s T2 Biosystems, Inc TTOO Stock Holding History

Balyasny Asset Management’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4
Closed -$29K – 2468
2021
Q1 		$29K Buy
+4
New +$42.4K ﹤0.01% 1700

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KFS
Kelly Financial Services Braintree, Massachusetts $467M AUM 21.13% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Balyasny Asset Management's TTOO Position: Q2 2021 in Review

Balyasny Asset Management sold out of T2 Biosystems, Inc (TTOO) in Q2 2021, closing a stake of 4 shares — an estimated $29K sold.

Balyasny Asset Management first reported a position in TTOO in Q1 2021 and held it in 1 quarter. The position peaked at $29K in Q1 2021. 78 funds tracked by Wall St. Rank hold TTOO as of Q2 2021.

  • Balyasny Asset Management reported no remaining T2 Biosystems, Inc position as of Q2 2021 after selling out during the quarter.
  • Balyasny Asset Management sold 4 T2 Biosystems, Inc shares in Q2 2021, an estimated $29K.
  • Balyasny Asset Management first reported a position in T2 Biosystems, Inc in Q1 2021 and held it in 1 quarter.
  • Balyasny Asset Management's T2 Biosystems, Inc position peaked at $29K in Q1 2021.
  • 78 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2021.

Based on Balyasny Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.